Cas:952065-58-6 N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline manufacturer & supplier

We serve Chemical Name:N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline CAS:952065-58-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline

Chemical Name:N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline
CAS.NO:952065-58-6
Synonyms:Np-G1;4,4′-[1,4-Naphthalenediyldi-(1E)-2,1-ethenediyl]bis[N,N-diphenylbenzenamine];4,4′-((1E,1’E)-Naphthalene-1,4-diylbis(ethene-2,1-diyl))bis(N,N-diphenylaniline)
Molecular Formula:C50H38N2
Molecular Weight:666.85000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.207
Index of Refraction:
PSA:6.48000
Exact Mass:666.30300
LogP:14.12020

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Np-G1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,4′-((1E,1’E)-Naphthalene-1,4-diylbis(ethene-2,1-diyl))bis(N,N-diphenylaniline) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Np-G1 Use and application,Np-G1 technical grade,usp/ep/jp grade.


Related News: Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline manufacturer Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline supplier Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems. N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline vendor Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. N,N-diphenyl-4-[2-[4-[2-[4-(N-phenylanilino)phenyl]ethenyl]naphthalen-1-yl]ethenyl]aniline factory Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research.